Overview
Using modeling and simulations, researchers can make informed decisions when planning and executing clinical trials. In particular, disease progression modeling leverages multiple types of data from various sources to inform trial design and support regulatory decision making. CTTI’s project, Using Disease Progression Modeling to Advance Trial Design and Decision Making, will advance the consistent application and integration of disease progression modeling for better decision making in clinical trials with the ultimate goal of bringing treatments to patients more efficiently. This work will also advance the broader application of modeling and simulations for designing clinical trials with a quality approach that maximally leverages available data — in alignment with CTTI’s Transforming Trials 2030 vision.
Solutions
Search AllRecommendation Summary
Recommendations
Resources
Related Items
-News
- CTTI Holds Meeting to Discuss Strategies for Advancing the Use and Acceptance of Disease Progression Modeling (DPM) in Clinical Trial Design & Decision MakingThe Clinical Trials Transformation Initiative (CTTI) held a multi-stakeholder expert meeting on March 6 to discuss strategies for advancing the use and acceptance of disease progression modeling (DPM) in clinical ...